These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 213180)

  • 1. Direct lymphocytotoxicity against herpes simplex virus infected cells.
    Fujimiya Y; Babiuk LA; Rouse BT
    Can J Microbiol; 1978 Sep; 24(9):1076-81. PubMed ID: 213180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
    Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
    Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
    J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural cytotoxic cell activity linked to time of recurrence of herpes labialis.
    Rola-Pleszczynski M; Lieu H
    Clin Exp Immunol; 1984 Jan; 55(1):224-8. PubMed ID: 6319058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
    Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA; Mendelsohn M; Lopez C
    J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis.
    Sethi KK; Stroehmann I; Brandis H
    Nature; 1980 Aug; 286(5774):718-20. PubMed ID: 6251371
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of naproxen therapy on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus.
    Gonik B; Loo LS; Bigelow R; Kohl S
    J Reprod Med; 1984 Oct; 29(10):722-6. PubMed ID: 6512781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell cytotoxicity and antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells in human pregnancy.
    Gonik B; Loo LS; West S; Kohl S
    Am J Reprod Immunol Microbiol; 1987 Jan; 13(1):23-6. PubMed ID: 3032009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity to herpes simplex virus in man. V. Antibody-mediated cell-dependent immune lysis of herpes virus-infected target cells.
    Russell AS; Kaiser JT
    J Allergy Clin Immunol; 1976 Nov; 58(5):539-45. PubMed ID: 185242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.
    Ching C; Lopez C
    Infect Immun; 1979 Oct; 26(1):49-56. PubMed ID: 227799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected autologous and allogeneic cells.
    Kohl S; Moore CM
    Immunology; 1983 Jan; 48(1):187-93. PubMed ID: 6848451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell cytotoxicity to herpes simplex virus-1-infected cells is not altered by pregnancy.
    Eriksen NL; Gonik B; Loo LS
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):965-8. PubMed ID: 1659194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells. Kinetics in normal donors and patients with recurrent herpes labialis.
    Rola-Pleszczynski M
    J Clin Lab Immunol; 1981 Jul; 6(1):39-43. PubMed ID: 7265173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis in human neonates of defective antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected cells.
    Kohl S; Loo LS; Gonik B
    J Infect Dis; 1984 Jul; 150(1):14-9. PubMed ID: 6086768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired natural killer cytotoxicity during recrudescence of recurrent herpes simplex virus type 1 infection.
    Kuo YC; Lin CY; Cheng SF; Lin CC; Liu WT
    Cancer Detect Prev Suppl; 1987; 1():51-5. PubMed ID: 3480065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    Tomescu C; Tebas P; Montaner LJ
    AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.